[Federal Register: April 16, 2004 (Volume 69, Number 74)]
[Page 20631-20632]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

[Docket No. 2003N-0267]

Agency Information Collection Activities; Announcement of OMB 
Approval; Postmarketing Studies for Human Drugs and Licensed Biological 
Products; Status Report

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Postmarketing Studies for Human 
Drugs and Licensed Biological Products; Status Report'' has been 
approved by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of January 16, 2004 
(69 FR 2601), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control

[[Page 20632]]

number. OMB has now approved the information collection and has 
assigned OMB control number 0910-0433. The approval expires on March 
31, 2007. A copy of the supporting statement for this information 
collection is available on the Internet at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/ohrms/dockets

    Dated: April 9, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-8612 Filed 4-15-04; 8:45 am]